Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2019

Open Access 01-12-2019 | Osteoporosis | Research article

Decreased fracture incidence with traditional Chinese medicine therapy in patients with osteoporosis: a nationwide population-based cohort study

Authors: Yu-Chi Wang, Jen-Huai Chiang, Hsin-Cheng Hsu, Chun-Hao Tsai

Published in: BMC Complementary Medicine and Therapies | Issue 1/2019

Login to get access

Abstract

Background

There are no published studies regarding the efficacy of traditional Chinese medicine (TCM) for the prevention of osteoporotic fracture. Therefore, we conducted this nationwide, population-based cohort study to investigate the probable effect of TCM to decrease the fracture rate.

Methods

We identified cases with osteoporosis and selected a comparison group that was frequency-matched according to sex, age (per 5 years), diagnosis year of osteoporosis, and index year. The difference between the two groups in the development of fracture was estimated using the Kaplan–Meier method and the log-rank test.

Results

After inserting age, gender, urbanization level, and comorbidities into the Cox’s proportional hazard model, patients who used TCM had a lower hazard ratio (HR) of fracture (adjusted HR: 0.47, 95% CI: 0.37–0.59) compared to the non-TCM user group. The Kaplan-Meier curves showed that osteoporosis patients who used TCM had a lower incidence of fracture events than those who did not (p < 0.00001). Our study also demonstrated that the longer the TCM use, the lesser the fracture rate.

Conclusion

Our study showed that TCM might have a positive impact on the prevention of osteoporotic fracture.
Literature
1.
go back to reference NCD P. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;6:285–785. NCD P. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;6:285–785.
2.
go back to reference (US) OotSG. Bone Health and Osteoporosis: A Report of the Surgeon General. In: Reports of the Surgeon General. edn. Edited by Rockville; 2004. (US) OotSG. Bone Health and Osteoporosis: A Report of the Surgeon General. In: Reports of the Surgeon General. edn. Edited by Rockville; 2004.
3.
go back to reference Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. K: Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(136). Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. K: Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(136).
4.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–75.CrossRef Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–75.CrossRef
6.
go back to reference Kinsella K, He W: U.S. Census Bureau, International Population Reports, P95/09–1. An Aging World: 2008, US Government Printing Office, Washington, DC 2009. Kinsella K, He W: U.S. Census Bureau, International Population Reports, P95/09–1. An Aging World: 2008, US Government Printing Office, Washington, DC 2009.
7.
go back to reference Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9.CrossRef Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9.CrossRef
8.
go back to reference Li TM, Huang HC, Su CM, Ho TY, Wu CM, Chen WC, Fong YC, Tang CH. Cistanche deserticola extract increases bone formation in osteoblasts. J Pharm Pharmacol. 2012;64(6):897–907.CrossRef Li TM, Huang HC, Su CM, Ho TY, Wu CM, Chen WC, Fong YC, Tang CH. Cistanche deserticola extract increases bone formation in osteoblasts. J Pharm Pharmacol. 2012;64(6):897–907.CrossRef
9.
go back to reference Guo AJ, Choi RC, Cheung AW, Chen VP, Xu SL, Dong TT, Chen JJ, Tsim KW. Baicalin, a flavone, induces the differentiation of cultured osteoblasts: an action via the Wnt/beta-catenin signaling pathway. J Biol Chem. 2011;286(32):27882–93.CrossRef Guo AJ, Choi RC, Cheung AW, Chen VP, Xu SL, Dong TT, Chen JJ, Tsim KW. Baicalin, a flavone, induces the differentiation of cultured osteoblasts: an action via the Wnt/beta-catenin signaling pathway. J Biol Chem. 2011;286(32):27882–93.CrossRef
10.
go back to reference GGX ML, Rong P, Dong J, Zhang Z, Zhao H, Teng J, Zhao H, Pan J, Li Y, Zha Q, Zhang Y, Ju D. Semen astragali complanati- and rhizoma cibotii-enhanced bone formation in osteoporosis rats. BMC Complement Altern Med. 2013;13(141). GGX ML, Rong P, Dong J, Zhang Z, Zhao H, Teng J, Zhao H, Pan J, Li Y, Zha Q, Zhang Y, Ju D. Semen astragali complanati- and rhizoma cibotii-enhanced bone formation in osteoporosis rats. BMC Complement Altern Med. 2013;13(141).
11.
go back to reference TP H, PH L, AS L, SL Y, HH C, Yen HR. Y: A nationwide population-based study of traditional Chinese medicine usage in children in Taiwan. Complement Ther Med. 2014;22(3):500–10.CrossRef TP H, PH L, AS L, SL Y, HH C, Yen HR. Y: A nationwide population-based study of traditional Chinese medicine usage in children in Taiwan. Complement Ther Med. 2014;22(3):500–10.CrossRef
13.
go back to reference Liu CYHY, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;14:1–22. Liu CYHY, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;14:1–22.
15.
go back to reference Black DM, AVS KEE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR. Effects of continuing or stopping alendronate after 5 years of treatment. JAMA. 2006;296(24). Black DM, AVS KEE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR. Effects of continuing or stopping alendronate after 5 years of treatment. JAMA. 2006;296(24).
16.
go back to reference Che CT, Wong MS, Lam CW. Natural products from Chinese medicines with potential benefits to bone health. Molecules. 2016;21(3):239.CrossRef Che CT, Wong MS, Lam CW. Natural products from Chinese medicines with potential benefits to bone health. Molecules. 2016;21(3):239.CrossRef
17.
go back to reference Feng XLY, Wu Z, Fang Y, Xu H, Zhao P, Xu Y, Feng H. Fructus ligustri lucidi ethanol extract improves bone mineral density and properties through modulating calcium absorption-related gene expression in kidney and duodenum of growing rats. Calcif Tissue Int. 2014;94(4):433–41.CrossRef Feng XLY, Wu Z, Fang Y, Xu H, Zhao P, Xu Y, Feng H. Fructus ligustri lucidi ethanol extract improves bone mineral density and properties through modulating calcium absorption-related gene expression in kidney and duodenum of growing rats. Calcif Tissue Int. 2014;94(4):433–41.CrossRef
18.
go back to reference Guo YLY, Xue L, Severino RP, Gao S, Niu J, Qin LP, Zhang D, Bromme D. Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti- osteoporotic drugs. J Ethnopharmacol. 2014;155(3):1401–16.CrossRef Guo YLY, Xue L, Severino RP, Gao S, Niu J, Qin LP, Zhang D, Bromme D. Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti- osteoporotic drugs. J Ethnopharmacol. 2014;155(3):1401–16.CrossRef
19.
go back to reference Berry SD, Miller RR. Falls: epidemiology, pathophysiology, and relationship to fracture. Curr Osteoporos Rep. 2008;6(4):149–54.CrossRef Berry SD, Miller RR. Falls: epidemiology, pathophysiology, and relationship to fracture. Curr Osteoporos Rep. 2008;6(4):149–54.CrossRef
20.
go back to reference Kannus PU-RK, Palvanen M, Parkkari J. Non-pharmacological means to prevent fractures among older adults. Ann Med. 2005;37:302–10.CrossRef Kannus PU-RK, Palvanen M, Parkkari J. Non-pharmacological means to prevent fractures among older adults. Ann Med. 2005;37:302–10.CrossRef
21.
go back to reference Svenhjalmar van Helden ACMvG, Piet P. Geusens, Alfons Kessels, Arie C. Nieuwenhuijzen Kruseman, Peter R.G. Brink: Bone and fall-related fracture risks in women and men with a recent clinical fracture. J Bone Joint Surg Am 2008, 90(241–248). Svenhjalmar van Helden ACMvG, Piet P. Geusens, Alfons Kessels, Arie C. Nieuwenhuijzen Kruseman, Peter R.G. Brink: Bone and fall-related fracture risks in women and men with a recent clinical fracture. J Bone Joint Surg Am 2008, 90(241–248).
22.
go back to reference Jä r TLSH, Khan KM, Heinonen A, Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ. 2008;336:124–6.CrossRef Jä r TLSH, Khan KM, Heinonen A, Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ. 2008;336:124–6.CrossRef
23.
go back to reference Chen BZH, Marszalek J, Chung M, Lin X, Zhang M, Pang J, Wang C. Traditional Chinese medications for knee osteoarthritis pain: a meta-analysis of randomized controlled trials. Am J Chin Med. 2016;44(4):677–703.CrossRef Chen BZH, Marszalek J, Chung M, Lin X, Zhang M, Pang J, Wang C. Traditional Chinese medications for knee osteoarthritis pain: a meta-analysis of randomized controlled trials. Am J Chin Med. 2016;44(4):677–703.CrossRef
24.
go back to reference Chen BZH, Chung M, Lin X, Zhang M, Pang J, Wang C. Chinese herbal Bath therapy for the treatment of knee osteoarthritis: meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2015;2015. Chen BZH, Chung M, Lin X, Zhang M, Pang J, Wang C. Chinese herbal Bath therapy for the treatment of knee osteoarthritis: meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2015;2015.
25.
go back to reference Yeh TSHC, Chuang HL, Hsu MC. Angelica sinensis improves exercise performance and protects against physical fatigue in trained mice. Molecules. 2014;19(4):3926–39.CrossRef Yeh TSHC, Chuang HL, Hsu MC. Angelica sinensis improves exercise performance and protects against physical fatigue in trained mice. Molecules. 2014;19(4):3926–39.CrossRef
26.
go back to reference Liu Y, Liu JP, Xia Y. Chinese herbal medicines for treating osteoporosis. Cochrane Database Syst Rev. 2014;3:CD005467. Liu Y, Liu JP, Xia Y. Chinese herbal medicines for treating osteoporosis. Cochrane Database Syst Rev. 2014;3:CD005467.
27.
go back to reference Johnell OGB, Allander E, Kanis JA. The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int. 1992;2:298–302.CrossRef Johnell OGB, Allander E, Kanis JA. The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int. 1992;2:298–302.CrossRef
28.
go back to reference Qi S, Zheng H, Chen C, Jiang H. Du-Zhong (Eucommia ulmoides Oliv.) cortex extract alleviates Lead acetate-induced bone loss in rats. Biol Trace Elem Res. 2018. Qi S, Zheng H, Chen C, Jiang H. Du-Zhong (Eucommia ulmoides Oliv.) cortex extract alleviates Lead acetate-induced bone loss in rats. Biol Trace Elem Res. 2018.
29.
go back to reference Zhang SZQ, Zhang D, Wang C, Yan C. Anti-osteoporosis activity of a novel Achyranthes bidentata polysaccharide via stimulating bone formation. Carbohydr Polym. 2018;184:288–98.CrossRef Zhang SZQ, Zhang D, Wang C, Yan C. Anti-osteoporosis activity of a novel Achyranthes bidentata polysaccharide via stimulating bone formation. Carbohydr Polym. 2018;184:288–98.CrossRef
30.
go back to reference D S, Z C, S H, J T, N L, H Q, X C, C W, K C, Y S, et al. Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signaling. J Cell Biochem. 2018;119(6):4826–35.CrossRef D S, Z C, S H, J T, N L, H Q, X C, C W, K C, Y S, et al. Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signaling. J Cell Biochem. 2018;119(6):4826–35.CrossRef
31.
go back to reference K K, Q L, X Y, Z X, Y W, J S, L C, W X, L H, H S: Asperosaponin VI promotes bone marrow stromal cell osteogenic differentiation through the PI3K/AKT signaling pathway in an osteoporosis model. Sci Rep 2016, 19(6):35233. K K, Q L, X Y, Z X, Y W, J S, L C, W X, L H, H S: Asperosaponin VI promotes bone marrow stromal cell osteogenic differentiation through the PI3K/AKT signaling pathway in an osteoporosis model. Sci Rep 2016, 19(6):35233.
32.
go back to reference GY S, H R, JJ H, ZD Z, WH Z, X Y, Q S, T Q, YZ Z, JJ T, et al. Plastrum Testudinis extracts promote BMSC proliferation and osteogenic differentiation by regulating let-7f-5p and the TNFR2/PI3K/AKT signaling pathway. Cell Physiol Biochem. 2018;47(6):2307–18.CrossRef GY S, H R, JJ H, ZD Z, WH Z, X Y, Q S, T Q, YZ Z, JJ T, et al. Plastrum Testudinis extracts promote BMSC proliferation and osteogenic differentiation by regulating let-7f-5p and the TNFR2/PI3K/AKT signaling pathway. Cell Physiol Biochem. 2018;47(6):2307–18.CrossRef
33.
go back to reference H R, G S, J T, T Q, Z Z, W Z, X Y, J H, Liang ZY, et al. Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine. Sci Rep. 2017;7(1):10617.CrossRef H R, G S, J T, T Q, Z Z, W Z, X Y, J H, Liang ZY, et al. Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine. Sci Rep. 2017;7(1):10617.CrossRef
34.
go back to reference D L, H R, T Q, G S, B X, Q W, Z Y, J T, Z Z, X J: Extracts from plastrum testudinis reverse glucocorticoid-induced spinal. Biomed Pharmacother 2016, 82:151–160. D L, H R, T Q, G S, B X, Q W, Z Y, J T, Z Z, X J: Extracts from plastrum testudinis reverse glucocorticoid-induced spinal. Biomed Pharmacother 2016, 82:151–160.
35.
go back to reference S S, Z G, X L, Y N, Y Z, C L, Y L, Z W. Total flavonoids of Drynariae Rhizoma prevent bone loss induced by Hindlimb unloading in rats. Molecules. 2017;22(7). S S, Z G, X L, Y N, Y Z, C L, Y L, Z W. Total flavonoids of Drynariae Rhizoma prevent bone loss induced by Hindlimb unloading in rats. Molecules. 2017;22(7).
36.
go back to reference SH S, YK Z, CQ L, Q Y, Y L, Y Z, WP H, ZZ W. Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro. Bone Rep. 2016;10(5):262–73. SH S, YK Z, CQ L, Q Y, Y L, Y Z, WP H, ZZ W. Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro. Bone Rep. 2016;10(5):262–73.
37.
go back to reference ZC Q, XL D, Y D GKX, XL W, KC W, MS W, XS Y. Discovery of a new class of Cathepsin K inhibitors in Rhizoma Drynariae as potential candidates for the treatment of osteoporosis. Int J Mol Sci. 2016;17(12). ZC Q, XL D, Y D GKX, XL W, KC W, MS W, XS Y. Discovery of a new class of Cathepsin K inhibitors in Rhizoma Drynariae as potential candidates for the treatment of osteoporosis. Int J Mol Sci. 2016;17(12).
38.
go back to reference JY W, WM C, CS W, SC H, PW C, JH C. Du-Huo-Ji-sheng-Tang and its active component Ligusticum chuanxiong promote osteogenic differentiation and decrease the aging process of human mesenchymal stem cells. J Ethnopharmacol. 2017;198:64–72.CrossRef JY W, WM C, CS W, SC H, PW C, JH C. Du-Huo-Ji-sheng-Tang and its active component Ligusticum chuanxiong promote osteogenic differentiation and decrease the aging process of human mesenchymal stem cells. J Ethnopharmacol. 2017;198:64–72.CrossRef
39.
go back to reference N L, Z Z, B W, X M, Y G, C Y, Z W, L W, R M, X L, et al. Regulatory effect of traditional Chinese medicinal formula Zuo-Gui-wan on the. J Ethnopharmacol. 2015;166:228–39.CrossRef N L, Z Z, B W, X M, Y G, C Y, Z W, L W, R M, X L, et al. Regulatory effect of traditional Chinese medicinal formula Zuo-Gui-wan on the. J Ethnopharmacol. 2015;166:228–39.CrossRef
Metadata
Title
Decreased fracture incidence with traditional Chinese medicine therapy in patients with osteoporosis: a nationwide population-based cohort study
Authors
Yu-Chi Wang
Jen-Huai Chiang
Hsin-Cheng Hsu
Chun-Hao Tsai
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2019
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2446-3

Other articles of this Issue 1/2019

BMC Complementary Medicine and Therapies 1/2019 Go to the issue